EV Biologics, Inc. (YECO)

EV Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2017
Net Income	-1.27	-21.06	-0.39	-0.1	-0.1
Depreciation & Amortization	0	0	0	0	0.69
Share-Based Compensation	0	0	0	0	0.16
Other Operating Activities	-2.02	0.21	1.09	0.2	0.8
Operating Cash Flow	-3.28	-20.84	0.7	0.1	1.55
Operating Cash Flow Growth	-	-	614.45%	-93.70%	-88.33%
Capital Expenditures	-0.04	0	-19.27	0	-1.93
Acquisitions	0	6.94	0	0	0
Other Investing Activities	10.84	12.85	-2.41	-	-
Investing Cash Flow	10.8	19.78	-21.68	0	-1.93
Common Stock Issued	0	0	0	0	0
Other Financing Activities	-7.72	1.99	21.68	-	-0.45
Financing Cash Flow	-7.72	1.99	21.68	0	-0.45
Net Cash Flow	-0.21	-0.26	0.5	0.1	-0.92
Free Cash Flow	-3.32	-20.84	-18.57	0.1	-0.38
Free Cash Flow Margin	-6793.78%	-	-15616.47%	-	-
Free Cash Flow Per Share	-0.32	-2.88	-2.57	0.01	-0.06

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.